🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us live on 4/20 for “WomenTalk: Beyond the Body — Perspectives From Real Women” as our own Luisa Santa-Coleman and Dr. Ariana Chao speak with 6 women who share their experiences living with obesity. blkwomenshealth OAC

Let’s change the #ObesityConversation together 🗣️ In our #BeyondTheBody videos, women living with obesity share their journeys. In partnership with the OAC Coalition through the Reclaim Your Wellness Campaign with blkwomenshealth. healthywomen.org/beyond-the-bod…

📢 TODAY Join us from 1pm - 2pm EST as we take a deep dive into the connection between the chronic disease of #Obesity and #MentalHealth. Register NOW via bit.ly/3wA84wG

Proof that the #Nursing future is bright! Stellar presentations by #BSN students from Jessica Abene Penn Nursing and Jadeion Saunders Howard University at the standing room only session on #SDOH at #ENRS2023. Mentors are Ariana M. Chao, PhD, CRNP and @fwphdrn.

#PRESS Novo Nordisk product reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in trial

Until we see a better supply of advanced #ObesityMeds and lower #prices, disparities in #obesity will only grow wider. Humanity cannot prosper with such extreme gaps in wealth and health. HT: Dr. Tiffani MD, MPH @AskDrFatima conscienhealth.org/2023/08/the-ga…

#Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with #HFpEF and #obesity ⬇️ #ESCCongress STEP-HFpEF trial

Exciting news! Vincent Guilamo-Ramos has been selected as director of "The Institute for Policy Solutions at the Johns Hopkins School of Nursing," a new health policy, research, and practice institute that will be based in Washington, DC! bit.ly/45CsghT

An oral agent that can help increase access to care for all people living with #obesity. #nejm in print this week.

Tirzepatide conferred an additional 18.4% weight loss for adults with #obesity who had already lost 6.9% of their body weight during intensive lifestyle intervention, according to data from SURMOUNT-3. #OW2023 ObesityWeek® Jamy D. Ard Ariana M. Chao, PhD, CRNP healio.com/news/endocrino…

Thrilled to share the impressive results from the SURMOUNT-3 trial at #OW2023 Check out the paper here 👇 nature.com/articles/s4159…

FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management. investor.lilly.com/news-releases/…

In the era of new generation anti-obesity medications, how does lifestyle modification fit in? Check out our new paper: The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Cli… pubmed.ncbi.nlm.nih.gov/38041774/

And other measures of #health like Body composition link.springer.com/article/10.100… John M. Jakicic, PhD Ariana M. Chao, PhD, CRNP

Huge congratulations to Jessica Abene on this well-deserved award! 🎉 Your talent shines bright and we can't wait to see what the future holds for you!

Beautifully comprehensive and thoughtful review of the current landscape of #lifestyle modification and its future, from Ariana M. Chao, PhD, CRNP at #CCOM2024 web.cvent.com/event/b827eab8…

Always a thoughtful and thought-provoking presentation from Ariana M. Chao, PhD, CRNP on the role of lifestyle modifications in modern #obesity #medicine Lifestyle... 👉 Is a component of comprehensive obesity care 👉 May play a larger role in determining quality of #weightloss than

SESSION 3 – ONE SIZE DOES NOT FIT ALL (chaired by Morin Marie-Philippe): Dr. J. Andrew Pospisilik will discuss how development and variegation underpin obesity subtypes, Dr. Ariana M. Chao, PhD, CRNP the future of behavioral obesity treatment, and Dr. Andres Acosta obesity management and treatment!